ABHD10 and alcoholic liver diseases: Analyses of human samples and murine models of alcoholic liver disease (ALD) reveal that the Elk-3 target Abhd10 ameliorates hepatotoxic injury and fibrosis in ALD by downregulating PRDX5 S-palmitoylation.